Digital Oncology Therapeutics Market Research Report – Segmentation By Product Type (Digital Therapeutics (DTx), Digital Diagnostics and Monitoring Tools, Digital Decision Support Systems, and Tele-oncology Solutions); Technology (AI and Ml, Big Data and Analytics, Mobile Health (mHealth) and Wearables, Internet of Medical Things (IoMT), Blockchain, Telemedicine, and Virtual Reality (VR) and Augmented Reality (AR)); Application (Cancer Screening and Diagnosis, Treatment Decision Support, Remote Patient Monitoring, Cancer Symptom and Side Effect Management, Patient Engagement and Education, Clinical Trials and Research); End-User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Cancer Research Institutes, Patients and Caregivers, Payers and Insurers); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-3280
Format:
Region: Global
Chapter 1. DIGITAL ONCOLOGY THERAPEUTICS MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. DIGITAL ONCOLOGY THERAPEUTICS MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. DIGITAL ONCOLOGY THERAPEUTICS MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. DIGITAL ONCOLOGY THERAPEUTICS MARK ET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. DIGITAL ONCOLOGY THERAPEUTICS MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. DIGITAL ONCOLOGY THERAPEUTICS MARKET – By Product Type
6.1. Digital Therapeutics (DTx)
6.2. Digital Diagnostics and Monitoring Tools
6.3. Digital Decision Support Systems
6.4. Tele-oncology Solutions
Chapter 7. DIGITAL ONCOLOGY THERAPEUTICS MARKET – By Technology
7.1. AI and ML
7.2. Big Data and Analytics
7.3. Mobile Health (mHealth) and Wearables
7.4. Internet of Medical Things (IoMT)
7.5. Blockchain
7.6. Telemedicine
7.7. VR and AR
Chapter 8. DIGITAL ONCOLOGY THERAPEUTICS MARKET – By Application
8.1. Cancer Screening and Diagnosis
8.2. Treatment Decision Support
8.3. Remote Patient Monitoring
8.4. Cancer Symptom and Side Effect Management
8.5. Patient Engagement and Education
8.6. Clinical Trials and Research
Chapter 9. DIGITAL ONCOLOGY THERAPEUTICS MARKET –By End User
9.1 Hospitals and Clinics
9.2. Pharmaceutical and Biotechnology Companies
9.3. Cancer Research Institutes
9.4. Patients and Caregivers
9.5. Payers and Insurers
Chapter 10. DIGITAL ONCOLOGY THERAPEUTICS MARKET – By Region
10.1. North America
10.2. Europe
10.3.The Asia Pacific
10.4.Latin America
10.5. Middle-East and Africa
Chapter 11. DIGITAL ONCOLOGY THERAPEUTICS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1. Amgen Inc.
11.2. AstraZeneca plc
11.3. Bayer AG
11.4. Bristol-Myers Squibb Company
11.5. Pfizer Inc
11.6. Novartis AG
11.7. Johnson & Johnson
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The market for Digital Oncology Therapeutics was estimated to be worth USD 1.58 billion in 2022, and it is projected to reach USD 3.18 billion by the end of 2030, growing at a CAGR of 9.15% over the forecast period
The Global Digital Oncology Therapeutics Market is driven by the growing integration and adoption of digital technologies across different industry verticals globally.
The Segments under the Global Digital Oncology Therapeutics Market by Product Type are Digital Therapeutics (DTx), Digital Diagnostics and Monitoring Tools, Digital Decision Support Systems, and Tele-oncology Solutions.
China, Japan, South Korea, Singapore, and India are the most dominating countries in the Asia Pacific region for the Global Digital Oncology Therapeutics Market.
Amgen Inc., AstraZeneca plc, Bayer AG, and Bristol-Myers Squibb Company.are the three major leading players in the Global Digital Oncology Therapeutics Market.
